Promise and limits of robotics in lung transplantation. ISHLT meeting
The expanding use of robotic technology in lung transplantation came under scrutiny at t46th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), where…
AI-powered ECG analysis offers promising path for early detection of chronic obstructive pulmonary disease
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality globally. Effective management hinges on early diagnosis, which is often impeded by non-specific symptoms and resource-intensive diagnostic…
Protecting infants against respiratory syncytial virus this winter — ECDC issues advice
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of…
Tumore al polmone a piccole cellule (ES-SCLC): FDA approva la combinazione lurbinectedina (Zepzelca®) e Atezolizumab (Tecentriq®) come terapia di mantenimento di prima linea
PharmaMar (MSE:PHM) ha annunciato che la Food and Drug Administration (FDA) statunitense ha concesso l’approvazione per Zepzelca® (lurbinectedina) in combinazione con atezolizumab (Tecentriq®) come trattamento di mantenimento per adulti con…
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…
One in 3,000 people at risk of punctured lung from faulty gene
As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a punctured lung, according to new estimates from Cambridge researchers. Previous…
Researchers identify signs tied to more severe cases of RSV
Respiratory syncytial virus (RSV) is the leading cause of hospitalization in young children due to respiratory complications such as bronchiolitis and pneumonia. Yet little is understood about why some children…
Vaping and smoking together increases lung cancer risk fourfold
People who both vape and smoke are four times more likely to develop lung cancer than people who just smoke, according to new study published by The Ohio State University…
Scientists pinpoint new drug target for RSV
Irish scientists led by a group from Trinity College Dublin have discovered how the dangerous Respiratory Syncytial Virus (RSV) defuses our immune response and, in doing so, they have pinpointed…
Talc is probably carcinogenic to humans
The International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has evaluated the carcinogenicity of talc and acrylonitrile. The outcome of the assessment…